Clonal hematopoiesis: linking hematopoietic stem cell aging with age-related diseases

Dykstra, B.; Olthof, S.; Schreuder, J.; et al. Clonal analysis reveals multiple functional defects of aged murine hematopoietic stem cells. J. Exp. Med. 2011, 208, 2691–2703.

Rossi, D. J.; Bryder, D.; Zahn, J. M.; et al. Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc. Natl. Acad. Sci. U. S. A. 2005, 102, 9194–9199.

Florian, M. C.; Dörr, K.; Niebel, A.; et al. Cdc42 activity regulates hematopoietic stem cell aging and rejuvenation. Cell Stem Cell 2012, 10, 520–530.

Beerman, I.; Bhattacharya, D.; Zandi, S. S.; et al. Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion. Proc. Natl. Acad. Sci. USA 2010, 107, 5465–5470.

Cho, R. H.; Sieburg, H. B.; Muller-Sieburg, C. E. A new mechanism for the aging of hematopoietic stem cells: Aging changes the clonal composition of the stem cell compartment but not individual stem cells. Blood 2008, 111, 5553–5561.

Köhler, A.; Schmithorst, V.; Filippi, M. D.; et al. Altered cellular dynamics and endosteal location of aged early hematopoietic progenitor cells revealed by time-lapse intravital imaging in long bones. Blood 2009, 114, 290–298.

Xing, Z. L.; Ryan, M. A.; Daria, D.; et al. Increased hematopoietic stem cell mobilization in aged mice. Blood 2006, 108, 2190–2197.

Geiger, H.; Koehler, A.; Gunzer, M. Stem cells, aging, niche, adhesion and Cdc42: A model for changes in cell-cell interactions and hematopoietic stem cell aging. Cell Cycle 2007, 6, 884–887.

Liang, Y.; Van Zant, G.; Szilvassy, S. J. Effects of aging on the homing and engraftment of murine hematopoietic stem and progenitor cells. Blood 2005, 106, 1479–1487.

Flach, J.; Bakker, S. T.; Mohrin, M.; et al. Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells. Nature 2014, 512, 198–202.

Norddahl, G. L.; Pronk, C. J.; Wahlestedt, M.; et al. Accumulating mitochondrial DNA mutations drive premature hematopoietic aging phenotypes distinct from physiological stem cell aging. Cell Stem Cell 2011, 8, 499–510.

Ito, K.; Hirao, A.; Arai, F.; et al. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat. Med. 2006, 12, 446–451.

Sun, D. Q.; Luo, M.; Jeong, M.; et al. Epigenomic profiling of young and aged HSCs reveals concerted changes during aging that reinforce self-renewal. Cell Stem Cell 2014, 14, 673–688.

Beerman, I.; Bock, C.; Garrison, B. S.; et al. Proliferation-dependent alterations of the DNA methylation landscape underlie hematopoietic stem cell aging. Cell Stem Cell 2013, 12, 413–425.

Li, J. J.; Liu, J. K.; Li, Y. E.; et al. Differentiation route determines the functional outputs of adult megakaryopoiesis. Immunity 2024, 57, 478–494.e6.

Poscablo, D. M.; Worthington, A. K.; Smith-Berdan, S.; et al. An age-progressive platelet differentiation path from hematopoietic stem cells causes exacerbated thrombosis. Cell 2024, 187, 3090–3107.e21.

Alter, B. P.; Rosenberg, P. S.; Giri, N.; et al. Telomere length is associated with disease severity and declines with age in dyskeratosis congenita. Haematologica 2012, 97, 353–359.

Rossi, D. J.; Bryder, D.; Seita, J.; et al. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 2007, 447, 725–729.

Steensma, D. P.; Bejar, R.; Jaiswal, S.; et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood 2015, 126, 9–16.

Mohrin, M.; Shin, J.; Liu, Y. F.; et al. Stem cell aging. A mitochondrial UPR-mediated metabolic checkpoint regulates hematopoietic stem cell aging. Science 2015, 347, 1374–1377.

Majewski, I. J.; Ritchie, M. E.; Phipson, B.; et al. Opposing roles of polycomb repressive complexes in hematopoietic stem and progenitor cells. Blood 2010, 116, 731–739.

Kamminga, L. M.; Bystrykh, L. V.; de Boer, A.; et al. The Polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion. Blood 2006, 107, 2170–2179.

Iwama, A.; Oguro, H.; Negishi, M.; et al. Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1. Immunity 2004, 21, 843–851.

Lessard, J.; Schumacher, A.; Thorsteinsdottir, U.; et al. Functional antagonism of the Polycomb-Group genes eed and Bmi1 in hemopoietic cell proliferation. Genes Dev. 1999, 13, 2691–2703.

Chambers, S. M.; Shaw, C. A.; Gatza, C.; et al. Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation. PLoS Biol. 2007, 5, e201.

Celso, C. L.; Scadden, D. T. The haematopoietic stem cell niche at a glance. J. Cell Sci. 2011, 124, 3529–3535.

Mitchell, C. A.; Verovskaya, E. V.; Calero-Nieto, F. J.; et al. Stromal niche inflammation mediated by IL-1 signalling is a targetable driver of haematopoietic ageing. Nat. Cell Biol. 2023, 25, 30–41.

Ergen, A. V.; Boles, N. C.; Goodell, M. A. Rantes/Ccl5 influences hematopoietic stem cell subtypes and causes myeloid skewing. Blood 2012, 119, 2500–2509.

Wagner, W.; Horn, P.; Bork, S.; et al. Aging of hematopoietic stem cells is regulated by the stem cell niche. Exp. Gerontol. 2008, 43, 974–980.

Frisch, B. J.; Hoffman, C. M.; Latchney, S. E.; et al. Aged marrow macrophages expand platelet-biased hematopoietic stem cells via Interleukin1B. JCI Insight 2019, 5, e124213.

Ambrosi, T. H.; Marecic, O.; McArdle, A.; et al. Aged skeletal stem cells generate an inflammatory degenerative niche. Nature 2021, 597, 256–262.

Ho, Y. H.; Del Toro, R.; Rivera-Torres, J.; et al. Remodeling of bone marrow hematopoietic stem cell niches promotes myeloid cell expansion during premature or physiological aging. Cell Stem Cell 2019, 25, 407–418.e6.

Franceschi, C.; Garagnani, P.; Morsiani, C.; et al. The continuum of aging and age-related diseases: Common mechanisms but different rates. Front. Med. (Lausanne) 2018, 5, 61.

Bogeska, R.; Mikecin, A. M.; Kaschutnig, P.; et al. Inflammatory exposure drives long-lived impairment of hematopoietic stem cell self-renewal activity and accelerated aging. Cell Stem Cell 2022, 29, 1273–1284.e8.

Kovtonyuk, L. V.; Caiado, F.; Garcia-Martin, S.; et al. IL-1 mediates microbiome-induced inflammaging of hematopoietic stem cells in mice. Blood 2022, 139, 44–58.

Higa, K. C.; Goodspeed, A.; Chavez, J. S.; et al. Chronic interleukin-1 exposure triggers selection for Cebpa-knockout multipotent hematopoietic progenitors. J. Exp. Med. 2021, 218, e20200560.

Agarwal, P.; Sampson, A.; Hueneman, K.; et al. Microbial metabolite drives ageing-related clonal haematopoiesis via ALPK1. Nature 2025, 642, 201–211.

Jaiswal, S.; Fontanillas, P.; Flannick, J.; et al. Age-related clonal hematopoiesis associated with adverse outcomes. N. Engl. J. Med. 2014, 371, 2488–2498.

Genovese, G.; Kähler, A. K.; Handsaker, R. E.; et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N. Engl. J. Med. 2014, 371, 2477–2487.

Girotra, M.; Chiang, Y. H.; Charmoy, M.; et al. Induction of mitochondrial recycling reverts age-associated decline of the hematopoietic and immune systems. Nat. Aging 2023, 3, 1057–1066.

Jan, M.; Snyder, T. M.; Corces-Zimmerman, M. R.; et al. Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia. Sci. Transl. Med. 2012, 4, 149ra118.

Avagyan, S.; Henninger, J. E.; Mannherz, W. P.; et al. Resistance to inflammation underlies enhanced fitness in clonal hematopoiesis. Science 2021, 374, 768–772.

Challen, G. A.; Sun, D. Q.; Jeong, M.; et al. Dnmt3a is essential for hematopoietic stem cell differentiation. Nat. Genet. 2011, 44, 23–31.

Moran-Crusio, K.; Reavie, L.; Shih, A.; et al. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell 2011, 20, 11–24.

Sasaki, M.; Knobbe, C. B.; Munger, J. C.; et al. IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics. Nature 2012, 488, 656–659.

Haferlach, T.; Nagata, Y.; Grossmann, V.; et al. Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia 2014, 28, 241–247.

Raaijmakers, M. H. G. P.; Mukherjee, S.; Guo, S. Q.; et al. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature 2010, 464, 852–857.

Kim, Y. W.; Koo, B. K.; Jeong, H. W.; et al. Defective Notch activation in microenvironment leads to myeloproliferative disease. Blood 2008, 112, 4628–4638.

Zimmer, S. N.; Zhou, Q.; Zhou, T.; et al. Crebbp haploinsufficiency in mice alters the bone marrow microenvironment, leading to loss of stem cells and excessive myelopoiesis. Blood 2011, 118, 69–79.

Medyouf, H.; Mossner, M.; Jann, J. C.; et al. Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit. Cell Stem Cell 2014, 14, 824–837.

Hanoun, M.; Zhang, D. C.; Mizoguchi, T.; et al. Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche. Cell Stem Cell 2014, 15, 365–375.

Muntión, S.; Ramos, T. L.; Diez-Campelo, M.; et al. Microvesicles from mesenchymal stromal cells are involved in HPC-microenvironment crosstalk in myelodysplastic patients. PLoS One 2016, 11, e0146722.

Ben-Batalla, I.; Schultze, A.; Wroblewski, M.; et al. Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine crosstalk of leukemia cells with bone marrow stroma. Blood 2013, 122, 2443–2452.

Zink, F.; Stacey, S. N.; Norddahl, G. L.; et al. Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly. Blood 2017, 130, 742–752.

Jaiswal, S.; Natarajan, P.; Silver, A. J.; et al. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N Engl J Med 2017, 377, 111–121.

Fuster, J. J.; MacLauchlan, S.; Zuriaga, M. A.; et al. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science 2017, 355, 842–847.

Wang, W.; Liu, W. L.; Fidler, T.; et al. Macrophage inflammation, erythrophagocytosis, and accelerated atherosclerosis in Jak2 ^V617F mice. Circ. Res. 2018, 123, e35–e47.

van Vlijmen, B. J.; Gerritsen, G.; Franken, A. L.; et al. Macrophage p53 deficiency leads to enhanced atherosclerosis in APOE*3-Leiden transgenic mice. Circ. Res. 2001, 88, 780–786.

Genetics Consortium Emerging Risk Factors Collaboration, I. L. 6. R.; Sarwar, N.; Butterworth, A. S.; et al. Interleukin-6 receptor pathways in coronary heart disease: A collaborative meta-analysis of 82 studies. Lancet 2012, 379, 1205–1213.

Ferreira, R. C.; Freitag, D. F.; Cutler, A. J.; et al. Functional IL6R 358Ala allele impairs classical IL-6 receptor signaling and influences risk of diverse inflammatory diseases. PLoS Genet. 2013, 9, e1003444.

Bick, A. G.; Pirruccello, J. P.; Griffin, G. K.; et al. Genetic interleukin 6 signaling deficiency attenuates cardiovascular risk in clonal hematopoiesis. Circulation 2020, 141, 124–131.

Hinds, D. A.; Barnholt, K. E.; Mesa, R. A.; et al. Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms. Blood 2016, 128, 1121–1128.

Wolach, O.; Sellar, R. S.; Martinod, K.; et al. Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms. Sci. Transl. Med. 2018, 10, eaan8292.

Dorsheimer, L.; Assmus, B.; Rasper, T.; et al. Association of mutations contributing to clonal hematopoiesis with prognosis in chronic ischemic heart failure. JAMA Cardiol. 2019, 4, 25–33.

Mas-Peiro, S.; Hoffmann, J.; Fichtlscherer, S.; et al. Clonal haematopoiesis in patients with degenerative aortic valve stenosis undergoing transcatheter aortic valve implantation. Eur. Heart J. 2020, 41, 933–939.

Sano, S.; Oshima, K.; Wang, Y.; et al. CRISPR-mediated gene editing to assess the roles of Tet2 and Dnmt3a in clonal hematopoiesis and cardiovascular disease. Circ. Res. 2018, 123, 335–341.

Sano, S.; Oshima, K.; Wang, Y.; et al. Tet2-mediated clonal hematopoiesis accelerates heart failure through a mechanism involving the IL-1β/NLRP3 inflammasome. J. Am. Coll. Cardiol. 2018, 71, 875–886.

Coombs, C. C.; Zehir, A.; Devlin, S. M.; et al. Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes. Cell Stem Cell 2017, 21, 374–382.e4.

Li, S. Q.; Feng, J. X.; Wu, F. Z.; et al. TET2 promotes anti-tumor immunity by governing G-MDSCs and CD8⁺ T-cell numbers. EMBO Rep. 2020, 21, e49425.

Ptashkin, R. N.; Mandelker, D. L.; Coombs, C. C.; et al. Prevalence of clonal hematopoiesis mutations in tumor-only clinical genomic profiling of solid tumors. JAMA Oncol. 2018, 4, 1589–1593.

Singh, A.; Trinchant, N. M.; Mishra, R.; et al. Immune checkpoint inhibitor therapy and associations with clonal hematopoiesis. Int. J. Mol. Sci. 2024, 25, 11049.

Pan, W.; Zhu, S.; Qu, K.; et al. The DNA methylcytosine dioxygenase Tet2 sustains immunosuppressive function of tumor-infiltrating myeloid cells to promote melanoma progression. Immunity 2017, 47, 284–297.e5.

Tian, R. Y.; Wiley, B.; Liu, J.; et al. Clonal hematopoiesis and risk of incident lung cancer. J. Clin. Oncol. 2023, 41, 1423–1433.

Zhang, C. R. C.; Nix, D.; Gregory, M.; et al. Inflammatory cytokines promote clonal hematopoiesis with specific mutations in ulcerative colitis patients. Exp. Hematol. 2019, 80, 36–41.e3.

Feng, Y.; Yuan, Q. C.; Newsome, R. C.; et al. Hematopoietic-specific heterozygous loss of Dnmt3a exacerbates colitis-associated colon cancer. J. Exp. Med. 2023, 220, e20230011.

Kleppe, M.; Comen, E.; Wen, H. Y.; et al. Somatic mutations in leukocytes infiltrating primary breast cancers. NPJ Breast Cancer 2015, 1, 15005.

Cohen Aubart, F.; Roos-Weil, D.; Armand, M.; et al. High frequency of clonal hematopoiesis in Erdheim-Chester disease. Blood 2021, 137, 485–492.

Kang, T. G.; Lan, X.; Mi, T.; et al. Epigenetic regulators of clonal hematopoiesis control CD8 T cell stemness during immunotherapy. Science 2024, 386, eadl4492.

Miller, P. G.; Gibson, C. J.; Mehta, A.; et al. Fitness landscape of clonal hematopoiesis under selective pressure of immune checkpoint blockade. JCO Precis. Oncol. 2020, 4, PO.20.00186.

Bouzid, H.; Belk, J. A.; Jan, M.; et al. Clonal hematopoiesis is associated with protection from Alzheimer’s disease. Nat. Med. 2023, 29, 1662–1670.

Hansen, D. V.; Hanson, J. E.; Sheng, M. Microglia in Alzheimer’s disease. J. Cell Biol. 2018, 217, 459–472.

Keogh, M. J.; Wei, W.; Aryaman, J.; et al. High prevalence of focal and multi-focal somatic genetic variants in the human brain. Nat. Commun. 2018, 9, 4257.

Wang, H.; Divaris, K.; Pan, B. H.; et al. Clonal hematopoiesis driven by mutated DNMT3A promotes inflammatory bone loss. Cell 2024, 187, 3690–3711.e19.

Kim, P. G.; Niroula, A.; Shkolnik, V.; et al. Dnmt3a-mutated clonal hematopoiesis promotes osteoporosis. J. Exp. Med. 2021, 218, e20211872.

Vlasschaert, C.; Robinson-Cohen, C.; Chen, J. C.; et al. Clonal hematopoiesis of indeterminate potential is associated with acute kidney injury. Nat. Med. 2024, 30, 810–817.

Agrawal, M.; Niroula, A.; Cunin, P.; et al. TET2-mutant clonal hematopoiesis and risk of gout. Blood 2022, 140, 1094–1103.

Miller, P. G.; Qiao, D. D.; Rojas-Quintero, J.; et al. Association of clonal hematopoiesis with chronic obstructive pulmonary disease. Blood 2022, 139, 357–368.

Wong, W. J.; Emdin, C.; Bick, A. G.; et al. Clonal haematopoiesis and risk of chronic liver disease. Nature 2023, 616, 747–754.

Bonnefond, A.; Skrobek, B.; Lobbens, S.; et al. Association between large detectable clonal mosaicism and type 2 diabetes with vascular complications. Nat. Genet. 2013, 45, 1040–1043.

Wu, D.; Hu, D.; Chen, H.; et al. Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer. Nature 2018, 559, 637–641.

Ramalingam, P.; Gutkin, M. C.; Poulos, M. G.; et al. Restoring bone marrow niche function rejuvenates aged hematopoietic stem cells by reactivating the DNA Damage Response. Nat. Commun. 2023, 14, 2018.

Maryanovich, M.; Zahalka, A. H.; Pierce, H.; et al. Adrenergic nerve degeneration in bone marrow drives aging of the hematopoietic stem cell niche. Nat. Med. 2018, 24, 782–791.

Satoh, Y.; Yokota, T.; Sudo, T.; et al. The Satb1 protein directs hematopoietic stem cell differentiation toward lymphoid lineages. Immunity 2013, 38, 1105–1115.

Wahlestedt, M.; Erlandsson, E.; Kristiansen, T.; et al. Clonal reversal of ageing-associated stem cell lineage bias via a pluripotent intermediate. Nat. Commun. 2017, 8, 14533.

Harrison, D. E.; Strong, R.; Sharp, Z. D.; et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009, 460, 392–395.

Mannick, J. B.; Del Giudice, G.; Lattanzi, M.; et al. mTOR inhibition improves immune function in the elderly. Sci. Transl. Med. 2014, 6, 268ra179.

Luo, H. Z.; Mu, W. C.; Karki, R.; et al. Mitochondrial stress-initiated aberrant activation of the NLRP3 inflammasome regulates the functional deterioration of hematopoietic stem cell aging. Cell Rep. 2019, 26, 945–954.e4.

Brown, K.; Xie, S.; Qiu, X. L.; et al. SIRT3 reverses aging-associated degeneration. Cell Rep. 2013, 3, 319–327.

Sun, X.; Cao, B.; Naval-Sanchez, M.; et al. Nicotinamide riboside attenuates age-associated metabolic and functional changes in hematopoietic stem cells. Nat. Commun. 2021, 12, 2665.

Ross, J. B.; Myers, L. M.; Noh, J. J.; et al. Depleting myeloid-biased haematopoietic stem cells rejuvenates aged immunity. Nature 2024, 628, 162–170.

Cheng, C. W.; Adams, G. B.; Perin, L.; et al. Prolonged fasting reduces IGF-1/PKA to promote hematopoietic-stem-cell-based regeneration and reverse immunosuppression. Cell Stem Cell 2014, 14, 810–823.

Lentz, M. J.; Killien, M. G. Are you sleeping? Sleep patterns during postpartum hospitalization. J. Perinat. Neonatal Nurs. 1991, 4, 30–38.

Woo, J.; Zhai, T. T.; Yang, F.; et al. Effect of clonal hematopoiesis mutations and canakinumab treatment on incidence of solid tumors in the CANTOS randomized clinical trial. Cancer Prev. Res. (Phila) 2024, 17, 429–436.

Miller, P. G.; Steensma, D. P. Implications of clonal hematopoiesis for precision oncology. JCO Precis. Oncol. 2020, 4, 639–646.

Ling, V. Y.; Lane, S. W. Clearing the way for new therapies in clonal hematopoiesis. Blood Adv 2023, 7, 7151–7152.

Hosseini, M.; Voisin, V.; Chegini, A.; et al. Metformin reduces the competitive advantage of Dnmt3aR878H HSPCs. Nature 2025, 642, 421–430.

Conboy, I. M.; Conboy, M. J.; Wagers, A. J.; et al. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 2005, 433, 760–764.

Yamamoto, R.; Wilkinson, A. C.; Ooehara, J.; et al. Large-scale clonal analysis resolves aging of the mouse hematopoietic stem cell compartment. Cell Stem Cell 2018, 22, 600–607.e4.

Geiger, H.; de Haan, G.; Florian, M. C. The ageing haematopoietic stem cell compartment. Nat Rev Immunol 2013, 13, 376–389.

Kaufmann, K. B.; Zeng, A. G. X.; Coyaud, E.; et al. A latent subset of human hematopoietic stem cells resists regenerative stress to preserve stemness. Nat. Immunol. 2021, 22, 723–734.

Fassoni, A. C.; Glauche, I. Math models expose myeloid bias mechanisms in hematopoiesis. Blood 2025, 145, 1231–1232.

Singh, A.; Chia, J. J.; Rao, D. S.; et al. Population dynamics modeling reveals that myeloid bias involves both HSC differentiation and progenitor proliferation biases. Blood 2025, 145, 1293–1308.

Xiong, H. Q.; Wang, Q. H.; Li, C. C.; et al. Single-cell joint profiling of multiple epigenetic proteins and gene transcription. Sci. Adv. 2024, 10, eadi3664.

Li, C. C.; Zhang, G. Y.; Du, J. J.; et al. Pre-configuring chromatin architecture with histone modifications guides hematopoietic stem cell formation in mouse embryos. Nat. Commun. 2022, 13, 346.

Mansell, E.; Lin, D. S.; Loughran, S. J.; et al. New insight into the causes, consequences, and correction of hematopoietic stem cell aging. Exp. Hematol. 2023, 125/126, 1–5.

Khan, A. O.; Rodriguez-Romera, A.; Reyat, J. S.; et al. Human bone marrow organoids for disease modeling, discovery, and validation of therapeutic targets in hematologic malignancies. Cancer Discov. 2023, 13, 364–385.